Skip to content

Metabolism of curcumin in healthy volunteers

Metabolism of curcumin in healthy volunteers - Metabolism of curcumin in healthy volunteers

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48906
Enrollment
9
Registered
2017-06-12
Start date
2018-04-16
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bioavailability and metabolisme of curcumin

Interventions

During 5 investigation fases, 5 different curcumin products will be taken orally. Each product will be taken once.

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Healthy male, age * 18 years * Able to give written informed consent * Willing to follow the dietary regimens * Able to complete the entire study

Exclusion criteria

Exclusion criteria: * Major illness in the past 3 months * Gastrointestinal disease * History of cholecystectomy or other bile duct abnormalities * Metabolic or endocrine diseases * Drug abuse or alcoholism (>3 units of alcohol per day) * Use of prescription or non-prescription drugs and herbal or dietary supplements within 30 days prior to the first administration of curcumin supplement. With the exclusion of (non)prescription drugs used for their local effect and thus have no influence on the kinetics of curcumin. * Use of tobacco products * High usage of curcumin and black pepper in daily food/beverages * Known intolerance for curcumin or black pepper * Participation in another clinical trial in the 3 months prior to the start of the study.

Design outcomes

Primary

MeasureTime frame
Kinetic parameters of curcumin: AUC, clearance, volume of distribution, elimination half-life and possible Cmax and Tmax concentrations.

Secondary

MeasureTime frame
Kinetic parameters of curcumin and piperine of each of the 5 products. Influence of curcumin and piperine on different biochemical parameters.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)